Standard Malaria Treatment Works Well Against Resistant Strains: Study
Intravenous artesunate was tested in Africa.
TL;DR
- Intravenous artesunate is effective against malaria strains resistant to the treatment.
- Children with resistant malaria strains had similar outcomes to those with non-resistant strains when treated with artesunate.
- The study involved 465 children hospitalized in Uganda between December 2022 and October 2024.
- Children received a minimum of three doses of intravenous artesunate.
- Artesunate is recommended by the WHO as the primary treatment for severe malaria.